Age-related macular degeneration: The importance of family history as a risk factor

British Journal of Ophthalmology

Volumn 96, Issue 3, 2012, Pages 427-431

  Shahid, Humma ^a,b   Khan, Jane C ^a,c   Cipriani, Valentina ^d   Sepp, Tiina ^a   Matharu, Baljinder K ^a   Bunce, Catey ^d   Harding, Simon P ^e   Clayton, David G ^a   Moore, Anthony T ^d   Yates, John R W ^a,d  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b OXFORD EYE HOSPITAL   (United Kingdom)

^c ROYAL PERTH HOSPITAL   (Australia)

^d MOORFIELDS EYE HOSPITAL   (United Kingdom)

^e UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; GENE LOCUS; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

AGED; CASE-CONTROL STUDIES; COMPLEMENT C3; COMPLEMENT FACTOR B; COMPLEMENT FACTOR H; FAMILY HEALTH; FEMALE; GENOTYPE; HUMANS; MACULAR DEGENERATION; MALE; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; PROTEINS; QUESTIONNAIRES; RISK FACTORS; SIBLING RELATIONS; VISION DISORDERS;

EID: 84857110934     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2011-300193     Document Type: Article

References (24)

1. Coleman HR, Chan CC, Ferris FL 3rd, et al. Age-related macular degeneration. Lancet 2008;372:1835-45.
2. Swaroop A, Chew EY, Rickman CB, et al. Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration. Annu Rev Genomics Hum Genet 2009;10:19-43.
3. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355:1419-31. (Pubitemid 44511557)
4. Hyman LG, Lilienfeld AM, Ferris FL 3rd, et al. Senile macular degeneration: a case-control study. Am J Epidemiol 1983;118:213-27. (Pubitemid 13029364)
5. Klein ML, Mauldin WM, Stoumbos VD. Heredity and age-related macular degeneration. Observations in monozygotic twins. Arch Ophthalmol 1994;112:932-7. (Pubitemid 24228253)
6. Meyers SM, Greene T, Gutman FA. A twin study of age-related macular degeneration. Am J Ophthalmol 1995;120:757-66.
7. Silvestri G, Johnston PB, Hughes AE. Is genetic predisposition an important risk factor in age-related macular degeneration? Eye (Lond) 1994;8:564-8. (Pubitemid 24331501)
8. De Jong PT, Klaver CC, Wolfs RC, et al. Familial aggregation of age-related maculopathy. Am J Ophthalmol 1997;124:862-3.
9. Seddon JM, Ajani UA, Mitchell BD. Familial aggregation of age-related maculopathy. Am J Ophthalmol 1997;123:199-206. (Pubitemid 27066775)
10. Klaver CC, Wolfs RC, Assink JJ, et al. Genetic risk of age-related maculopathy. Population-based familial aggregation study. Arch Ophthalmol 1998;116:1646-51. (Pubitemid 29001964)
11. Smith W, Mitchell P. Family history and age-related maculopathy: the Blue Mountains Eye Study. Aust N Z J Ophthalmol 1998;26:203-6. (Pubitemid 28372494)
12. Klein BE, Klein R, Lee KE, et al. Risk of incident age-related eye diseases in people with an affected sibling: the Beaver Dam Eye study. Am J Epidemiol 2001;154:207-11. (Pubitemid 32701155)
13. Hammond CJ, Webster AR, Snieder H, et al. Genetic influence on early age-related maculopathy: a twin study. Ophthalmology 2002;109:730-6. (Pubitemid 34272274)
14. Seddon JM, Cote J, Page WF, et al. The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch Ophthalmol 2005;123:321-7. (Pubitemid 41007575)
15. Gottfredsdottir MS, Sverisson T, Musch DC, et al. Age-related macular degeneration in monozygotic twins and their spouses in Iceland. Acta Ophthalmol Scand 1999;77:422-5. (Pubitemid 29368859)
16. Heiba IM, Elston RC, Klein BE, et al. Sibling correlations and segregation analysis of age-related maculopathy: the Beaver Dam Eye Study. Genet Epidemiol 1994;11:51-67. (Pubitemid 24089911)
17. Khan JC, Thurlby DA, Shahid H, et al. Smoking and age-related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. Br J Ophthalmol 2006;90:75-80. (Pubitemid 43029901)
18. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Ophthalmology 1995;39:367-74.
19. Ferris FL, Davis MD, Clemons TE, et al Age-related Eye Disease Study Research Group. A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol 2005;123:1570-4. (Pubitemid 41626694)
20. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. The Beaver Dam Eye study. Ophthalmology 1992;99:933-43.
21. Mitchell P, Smith W, Attebo K. Prevalence of Age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 1995;102:1450-60.
22. Vingerling JR, Dielemans I, Hofman A. The prevalence of age-related maculopathy in the Rotterdam Eye study. Ophthalmology 1995;102:205-10.
23. Jonasson F, Arnarsson A, Sasaki H, et al. The prevalence of age-related maculopathy in Iceland: Reykjavik eye study. Arch Ophthalmol 2003;121:379-85. (Pubitemid 36298121)
24. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and visual loss: AREDS report no.8. Arch Ophthalmol 2001;119:1417-36.